DE60036937D1 - HUMANE GIL-19/AE289 PROTEINE UND DAFüR KODIERENDE POLYNUKLEOTIDE - Google Patents
HUMANE GIL-19/AE289 PROTEINE UND DAFüR KODIERENDE POLYNUKLEOTIDEInfo
- Publication number
- DE60036937D1 DE60036937D1 DE60036937T DE60036937T DE60036937D1 DE 60036937 D1 DE60036937 D1 DE 60036937D1 DE 60036937 T DE60036937 T DE 60036937T DE 60036937 T DE60036937 T DE 60036937T DE 60036937 D1 DE60036937 D1 DE 60036937D1
- Authority
- DE
- Germany
- Prior art keywords
- gil
- humane
- proteins
- polynucleotide coding
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13147399P | 1999-04-28 | 1999-04-28 | |
US131473P | 1999-04-28 | ||
PCT/US2000/011479 WO2000065027A2 (en) | 1999-04-28 | 2000-04-28 | Human gil-19/ae289 proteins and polynucleotides encoding same |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60036937D1 true DE60036937D1 (de) | 2007-12-13 |
DE60036937T2 DE60036937T2 (de) | 2008-08-07 |
Family
ID=22449618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60036937T Expired - Lifetime DE60036937T2 (de) | 1999-04-28 | 2000-04-28 | HUMANE GIL-19/AE289 PROTEINE UND DAFüR KODIERENDE POLYNUKLEOTIDE |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP2357193B1 (de) |
JP (2) | JP4828703B2 (de) |
AT (1) | ATE377077T1 (de) |
BR (1) | BR0010097A (de) |
CA (1) | CA2367965C (de) |
CY (1) | CY1107138T1 (de) |
DE (1) | DE60036937T2 (de) |
DK (1) | DK1177312T3 (de) |
ES (2) | ES2295026T3 (de) |
HK (2) | HK1041021A1 (de) |
MX (1) | MXPA01010883A (de) |
NZ (1) | NZ515678A (de) |
PT (1) | PT1177312E (de) |
WO (1) | WO2000065027A2 (de) |
ZA (1) | ZA200109270B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002016611A2 (en) * | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
US6551799B2 (en) | 1999-12-07 | 2003-04-22 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
WO2000024758A1 (en) | 1998-10-26 | 2000-05-04 | Ludwig Institute For Cancer Research | ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
US6274710B1 (en) * | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
DK1177312T3 (da) * | 1999-04-28 | 2008-02-25 | Genetics Inst Llc | Humane GIL-19/AE289-proteiner og polynukleotider kodende derfor |
ATE458814T1 (de) | 1999-12-03 | 2010-03-15 | Zymogenetics Inc | Menschliches zytokinrezeptor |
US7226591B2 (en) | 2000-05-22 | 2007-06-05 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
EP2194130A1 (de) * | 1999-12-23 | 2010-06-09 | ZymoGenetics, L.L.C. | Zytokin ZCYT018 |
US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
EP1806404B1 (de) * | 2000-07-27 | 2010-08-18 | Wyeth LLC | Verwendung von IL-10 Rezeptor beta antagonistische Antikörper zur Hemmung einer IL-TIF/IL-21 Induktion von Akutphasen-Proteine |
CA2418950A1 (en) | 2000-08-08 | 2002-02-14 | Zymogenetics, Inc. | Soluble zcytor 11 cytokine receptors |
US7094570B2 (en) | 2003-03-11 | 2006-08-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
WO2002068476A2 (en) * | 2001-02-23 | 2002-09-06 | Genetics Institute, Llc | Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
CA2439961A1 (en) | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
US7033787B2 (en) | 2001-12-21 | 2006-04-25 | Ludwig Institute For Cancer Research | Isolated cytokine receptor LICR-2 |
CA2480163A1 (en) | 2002-03-22 | 2003-10-09 | Zymogenetics, Inc. | Anti-il-tif antibodies and methods of using in inflammation |
ATE475673T1 (de) | 2003-03-24 | 2010-08-15 | Zymogenetics Inc | Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung |
US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
EP1812476B1 (de) | 2004-10-22 | 2010-07-21 | ZymoGenetics, Inc. | Anti-il-22ra-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen |
US8524678B2 (en) | 2005-05-31 | 2013-09-03 | The Regents Of The University Of Colorado, A Body Corporate | Method for delivering genes |
PE20151673A1 (es) | 2013-03-15 | 2015-11-27 | Genentech Inc | POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US5169939A (en) | 1985-05-21 | 1992-12-08 | Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College | Chimeric antibodies |
US4798885A (en) | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5576184A (en) | 1988-09-06 | 1996-11-19 | Xoma Corporation | Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5126323A (en) | 1989-11-16 | 1992-06-30 | Genetics Institute, Inc. | Homogeneous purified k-fgf and compositions containing the same |
US5614396A (en) | 1990-06-14 | 1997-03-25 | Baylor College Of Medicine | Methods for the genetic modification of endogenous genes in animal cells by homologous recombination |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5194594A (en) | 1990-09-07 | 1993-03-16 | Techniclone, Inc. | Modified antibodies |
PT101031B (pt) | 1991-11-05 | 2002-07-31 | Transkaryotic Therapies Inc | Processo para o fornecimento de proteinas por terapia genetica |
US5536637A (en) | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
US6664107B1 (en) | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
JPH09501932A (ja) | 1993-08-26 | 1997-02-25 | ジェネティックス・インスティテュート・インコーポレイテッド | ヒト・骨形態形成蛋白を用いる神経再生 |
ES2255059T3 (es) | 1993-12-07 | 2006-06-16 | Genetics Institute, Llc | Bmp-12, bmp-13 y composiciones suyas inductoras de tendon. |
US5679523A (en) | 1995-11-16 | 1997-10-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method for concurrent disruption of expression of multiple alleles of mammalian genes |
US6274710B1 (en) * | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
WO2000024758A1 (en) * | 1998-10-26 | 2000-05-04 | Ludwig Institute For Cancer Research | ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
DK1177312T3 (da) * | 1999-04-28 | 2008-02-25 | Genetics Inst Llc | Humane GIL-19/AE289-proteiner og polynukleotider kodende derfor |
WO2000073457A1 (en) * | 1999-05-27 | 2000-12-07 | Schering-Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
US20020187512A1 (en) * | 2001-09-10 | 2002-12-12 | Nagem Ronaldo Alves Pinto | Crystal structure of human interleukin-22 |
TWI417301B (zh) * | 2006-02-21 | 2013-12-01 | Wyeth Corp | 對抗人類介白素-22(il-22)之抗體及其用途 |
-
2000
- 2000-04-28 DK DK00928535T patent/DK1177312T3/da active
- 2000-04-28 NZ NZ515678A patent/NZ515678A/xx not_active IP Right Cessation
- 2000-04-28 EP EP10185792.8A patent/EP2357193B1/de not_active Expired - Lifetime
- 2000-04-28 JP JP2000614364A patent/JP4828703B2/ja not_active Expired - Fee Related
- 2000-04-28 DE DE60036937T patent/DE60036937T2/de not_active Expired - Lifetime
- 2000-04-28 ES ES00928535T patent/ES2295026T3/es not_active Expired - Lifetime
- 2000-04-28 ES ES07119666T patent/ES2530857T3/es not_active Expired - Lifetime
- 2000-04-28 MX MXPA01010883A patent/MXPA01010883A/es active IP Right Grant
- 2000-04-28 WO PCT/US2000/011479 patent/WO2000065027A2/en active IP Right Grant
- 2000-04-28 CA CA2367965A patent/CA2367965C/en not_active Expired - Lifetime
- 2000-04-28 AT AT00928535T patent/ATE377077T1/de active
- 2000-04-28 BR BR0010097-8A patent/BR0010097A/pt not_active IP Right Cessation
- 2000-04-28 PT PT00928535T patent/PT1177312E/pt unknown
- 2000-04-28 EP EP00928535A patent/EP1177312B1/de not_active Expired - Lifetime
-
2001
- 2001-11-09 ZA ZA200109270A patent/ZA200109270B/xx unknown
-
2002
- 2002-03-09 HK HK02101816A patent/HK1041021A1/xx not_active IP Right Cessation
-
2008
- 2008-01-14 CY CY20081100050T patent/CY1107138T1/el unknown
- 2008-09-12 HK HK08110203.4A patent/HK1118576A1/xx not_active IP Right Cessation
-
2011
- 2011-02-21 JP JP2011034204A patent/JP2011160804A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2295026T3 (es) | 2008-04-16 |
EP1177312A4 (de) | 2004-08-25 |
JP4828703B2 (ja) | 2011-11-30 |
NZ515678A (en) | 2004-01-30 |
ZA200109270B (en) | 2002-11-13 |
EP2357193A1 (de) | 2011-08-17 |
JP2003527078A (ja) | 2003-09-16 |
EP2357193B1 (de) | 2015-11-04 |
CY1107138T1 (el) | 2012-10-24 |
CA2367965A1 (en) | 2000-11-02 |
CA2367965C (en) | 2015-12-01 |
EP1177312A2 (de) | 2002-02-06 |
DK1177312T3 (da) | 2008-02-25 |
WO2000065027A2 (en) | 2000-11-02 |
BR0010097A (pt) | 2002-02-13 |
HK1118576A1 (en) | 2009-02-13 |
MXPA01010883A (es) | 2002-10-31 |
EP1177312B1 (de) | 2007-10-31 |
ATE377077T1 (de) | 2007-11-15 |
PT1177312E (pt) | 2008-01-22 |
WO2000065027A3 (en) | 2001-04-05 |
JP2011160804A (ja) | 2011-08-25 |
HK1041021A1 (en) | 2002-06-28 |
ES2530857T3 (es) | 2015-03-06 |
DE60036937T2 (de) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60036937D1 (de) | HUMANE GIL-19/AE289 PROTEINE UND DAFüR KODIERENDE POLYNUKLEOTIDE | |
DE60330923D1 (de) | Menschliche Koagulationsfaktor VII Polypeptide | |
ATE407949T1 (de) | Charakterisierung der proteinfamilie von soc/crac kalziumkanälen | |
DK0409472T3 (da) | Knoglemorfogenetisk protein | |
DK0733067T3 (da) | N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder | |
DE69007823T2 (de) | Behandeltes Siliziumdioxid zur Verstärkung von Silikonelastomer. | |
ATE96840T1 (de) | Fuer die direkte expression von aktiviertem menschlichen protein-c verwendbare vektoren und zusammensetzungen. | |
ATE259243T1 (de) | Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse | |
FI900808A0 (fi) | Humant mannos bindande protein. | |
DE69841994D1 (de) | 32 Humane sekretierte Proteine | |
DE69117123T2 (de) | Menschliches MK Gen und Protein-Sequenz | |
ATE265226T1 (de) | Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin- abhängiger krankheiten | |
DE68918673T2 (de) | IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung. | |
ATE126273T1 (de) | Immunogenes protein und cdna-klon. | |
ATE218616T1 (de) | Humanes zirkulierendes cytokin cc-1 | |
ATE315092T1 (de) | Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen | |
HUP9900789A2 (hu) | Lefelé irányuló szabályozásra rezisztens C3 konvertáz | |
EP1220896A4 (de) | NEUE HUMANE LIPASEPROTEINE, DAFüR KODIERENDE NUKLEINSäUREN UND DEREN VERWENDUNGEN | |
EP1897950A3 (de) | Humane GIL-19/AE289-Proteine und dafür kodierende Polynukleotide | |
DE69728936D1 (de) | Polypeptid menschlicher Glykosaminglykan Sulfotransferase und dafür kodierende DNS | |
ATE329032T1 (de) | Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff | |
IT1202565B (it) | Purificazione di interleuchina-1 umana ricombinante | |
FR2602586B1 (fr) | Manipulateur analogique de parametres de son et de variation d'intensite lumineuse ou autres codages | |
SE9703137D0 (sv) | Novel treatment of autoimmune diseases | |
ATE52277T1 (de) | Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |